Antiviral efficacy of bromo-anilino substituents of 4,5-dihydrofuran-3-carboxylate compound CW-33 against Japanese encephalitis virus

https://doi.org/10.1016/j.bmcl.2019.126742Get rights and content

Highlights

  • •

    A bromo substitution (CW-33K) on at the C-2 anilino ring of CW-33 improved the antiviral activity JEV.

  • •

    CW-33K exhibited the highest antiviral efficacy, which IC50 value was less than 5 μM.

  • •

    CW-33K significantly inhibited the JEV replication at the early and late stages.

Abstract

Japanese encephalitis virus (JEV), a mosquito-borne flavivirus, occasionally causes severe central nervous system disorders in the risk zone where more than 3 billion people reside. Our prior studies demonstrated antiviral potential of 4,5-dihydrofuran-3-carboxylate compound CW-33 (ethyl 2-(3′,5′-dimethylanilino)-4-oxo-4,5-dihydrofuran-3-carboxylate) and its derivative CW-33A ((ethyl 2-(2-fluoroanilino)-4-oxo-4,5-dihydrofuran-3-carboxylate) against JEV infection ((Int. J. Mol. Sci. 2016, 17: E1386; Sci. Rep. 2018, 8: 16595). This study synthesized six new CW-33 derivatives containing chloro, or bromo groups at the C-2, C-3, or C-4 of anilino ring of CW-33, and assessed the antiviral activity and mechanisms of these chloro- and bromo-anilino substituted derivatives. CW-33K, CW-33L and CW-33M had the bromo-substituents at the C-2, C-3, or C-4 of anilino ring of CW-33, respectively, showing the higher anti-JEV activity than CW-33 and other derivatives. CW-33K (ethyl 2-(2-bromoanilino)-4-oxo-4,5-dihydrofuran-3-carboxylate) exhibited the highest antiviral efficacy and therapeutic index. The IC50 value of CW-33K was less than 5 μM for reducing JEV-induced cytopathic effect, virus infectivity and virus yield. CW-33K significantly inhibited the JEV replication at the early and late stages, suppressing viral RNA synthesis and intracellular JEV particle production. The study demonstrated that the CW-33 derivative with a bromo substitution at the C-2 anilino ring improved the antiviral activity JEV, providing the structure-antiviral activity relationship for the development of anti-JEV agents.

Section snippets

Competing interests

JC Lien, AC Huang, and CW Lin had patents on CW-33 derivatives.

Acknowledgements

This study was supported by China Medical University (Taiwan) under the Aim for Top University Plan of the Ministry of Education, Taiwan (CHM106-6-2). This project was also funded by grants from the Ministry of Science and Technology, Taiwan (MOST107-2923-B-039-001-MY3, MOST105-2320-B-039-053-MY3,) and China Medical University, Taiwan (CMU106-BC-1, CMU106-ASIA-06, CMU107-ASIA-12, and CMU107-S-14).

References (25)

  • L.L. Coffey et al.

    Factors shaping the adaptive landscape for arboviruses: implications for the emergence of disease

    Fut Microbiol

    (2013)
  • H.M. Lazear et al.

    Zika virus: new clinical syndromes and its emergence in the Western Hemisphere

    J Virol

    (2016)
  • T. Solomon et al.

    Origin and evolution of Japanese encephalitis virus in southeast Asia

    J Virol

    (2003)
  • World Health Organization

    Japanese Encephalitis

    (2019)
  • H.J. Seo et al.

    Molecular detection and genotyping of Japanese encephalitis virus in mosquitoes during a 2010 outbreak in the Republic of Korea

    PLoS One

    (2013)
  • Y.Y. Chen et al.

    Japanese encephalitis virus genotype replacement, Taiwan, 2009–2010

    Emerg Infect Dis

    (2011)
  • S.M. Yun et al.

    Molecular epidemiology of Japanese encephalitis virus circulating in South Korea, 1983–2005

    Virol J

    (2010)
  • Y.C. Fan et al.

    Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine

    PLoS Negl Trop Dis

    (2012)
  • J.F. Lindahl et al.

    Circulation of Japanese encephalitis virus in pigs and mosquito vectors within Can Tho city, Vietnam

    PLoS Negl Trop Dis

    (2013)
  • C.Y. Wang et al.

    Antiviral potential of a novel compound CW-33 against enterovirus A71 via inhibition of viral 2A protease

    Viruses

    (2015)
  • S.H. Huang et al.

    Antiviral activity of a novel compound CW-33 against Japanese encephalitis virus through inhibiting intracellular calcium overload

    Int J Mol Sci

    (2016)
  • K.C. Chen et al.

    Molecular interaction of the antiviral compound CW–33 and its analogues with the NS2B–NS3 protease of the Japanese encephalitis virus

    Int J Mol Med

    (2019)
    • k

    Co-first author.

    View full text
    © 2019 Elsevier Ltd. All rights reserved.